Statistics for Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
Total visits
| views | |
|---|---|
| Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors | 4 |
Total visits per month
| views | |
|---|---|
| June 2024 | 1 |
| July 2024 | 1 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| nihms-1835750.pdf | 20 |
Top country views
| views | |
|---|---|
| United States | 3 |
| United Kingdom | 1 |
Top city views
| views | |
|---|---|
| Indianapolis | 2 |
| Boston | 1 |
| Louth | 1 |